In partnership with the Weitzman Institute, the New England Regional Genetics Network is excited to announce a special Weitzman ECHO Complex Integrated Pediatrics session focused on autism and neurological genetics in pediatric and adolescent populations. Providers and their care teams are invited to register for this session, or the full 9-month ECHO program.
March 18, 2019: Autism Spectrum Disorder: Genetic and Neurological Perspectives
1 p.m. to 2:30 p.m. EST
About Weitzman ECHO Complex Integrated Pediatrics
Weitzman ECHO Complex Integrated Pediatrics is a 9-month program that uses twice monthly videoconferencing sessions to connect primary care medical and behavioral health providers with a multidisciplinary team of specialists to improve the quality of care and clinical outcomes for underserved children and adolescents. During each 90-minute session, the specialist team delivers educational presentations on key issues in pediatric health including asthma management, genetic screening, obesity, diabetes, suicide/self-harm, autism, and cardiology, and provides recommendations on challenging cases posed by participants.
About the Presenter
- Leah W. Burke, MD: Dr. Burke is board certified in both Clinical Genetics and Pediatrics. She serves as the Director of the University of Vermont Medical Center Clinical Genetics Program and is a professor in the UVM College of Medicine. She also serves on the Council of Genetics for the American Academy of Pediatrics and on the board of the New England Regional Genetics Network. She has been regionally and nationally involved in ensuring that the education of genetics and genomics is continued at the postgraduate and continuing education level.
- Louisa Kalsner, MD: Dr. Kalsner is a Doctor primarily located in Hartford, CT. She has 22 years of experience. Her specialties include Child Neurology and Medical Genetics. Dr. Kalsner is also an Assistant professor of Pediatrics Neurology at the University of Connecticut School of Medicine. Her clinical expertise is in areas such as metabolic and genetic disorders, mitochondrial diseases, and epilepsy.
- If you are registering for this genetic session only: After you comple the registration form, we will send you session access details and a calendar invitation. You will also receive a session agenda on the morning of the session.
- If you are registering for the full, 9-month program: After you complete the registration form, we will follow up with an Agreement for you to sign which will explain the requirements of the program and confirm your participation.
If you have any questions, please contact Janet Oputa, Program Coordinator, at [email protected].
The NERGN project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number UH7MC30778; New England Regional Genetics Network; total award amount: 1.5 million; 100% from governmental sources. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.